Mineralys Therapeutics, Inc. (MLYS) insider trading

By person

16 insiders · 177 transactions

24.1×

Jon Congleton holds 24.1 times base salary in stock. $15.37M of shares against $636.50K in salary for 2025.

Salary from the company's own proxy. The shares are what Jon Congleton last reported holding, valued at $25.46, the price Common Stock was last bought or sold at on the open market here, on 30 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Ra Capital Management, L.p. entity

Director

$76.26M (6)

—

+$76.26M

5,825,521

6.59%

$148.33M

—

Brian Taylor Slingsby

Director

$7.50M (2)

$53.53M (3)

−$46.03M

15,715,756

17.78%

$400.16M

+25.3%

Srinivas Akkaraju

Director

$38.10M (3)

—

+$38.10M

594,435

0.6724%

$15.14M

—

David Malcom Rodman

Chief Medical Officer

—

$19.98M (57) scheduled

−$19.98M

51,384

0.0581%

$1.31M

+674.8%

Jon Congleton

Chief Executive Officer

$105.54K (4)

$19.33M (29) scheduled

−$19.23M

528,621

0.5979%

$13.46M

−49.1%

Samsara BioCapital GP, LLC entity

10% owner

$15.60M (2)

—

+$15.60M

5,674,916

6.42%

$144.50M

+25.6%

Adam Scott Levy

CFO and Secretary

$100.00K (1)

$9.16M (23) scheduled

−$9.06M

48,538

0.0549%

$1.24M

−81.5%

HBM Healthcare Investments (Cayman) Ltd. entity

10% owner

$5.00M (1)

—

+$5.00M

3,218,106

3.64%

$81.94M

—

Eric Warren

Chief Commercial Officer

—

$3.30M (4) scheduled

−$3.30M

38,400

0.0434%

$977.75K

0.0%

Alexander M Gold

Director

—

$1.58M (5) scheduled

−$1.58M

6,200

0.0070%

$157.87K

—

Daphne Karydas

Director

—

$925.54K (5) scheduled

−$925.54K

6,200

0.0070%

$157.87K

—

James J. Ferguson III

Chief Medical Officer

—

102,400

0.1158%

$2.61M

—

Lonnel Coats

Director

—

12,400

0.0140%

$315.73K

—

Kristine Peterson

Director

—

12,400

0.0140%

$315.73K

—

Glenn Sblendorio

Director

—

6,200

0.0070%

$157.87K

—

Derek DiRocco

Director

—

6,200

0.0070%

$157.87K

—

Mineralys Therapeutics, Inc.

What the insiders did Net buying

By person